Skip to main content

Main menu

  • Home
  • Current Issue
  • Archive
  • Info for
    • Authors
    • Editorial Policies
    • Subscribers
    • Advertisers
    • Editorial Board
    • Special Issues
  • Journal Metrics
  • Other Publications
    • In Vivo
    • Cancer Genomics & Proteomics
    • Cancer Diagnosis & Prognosis
  • More
    • IIAR
    • Conferences
    • 2008 Nobel Laureates
  • About Us
    • General Policy
    • Contact
  • Other Publications
    • Anticancer Research
    • In Vivo
    • Cancer Genomics & Proteomics

User menu

  • Register
  • Subscribe
  • My alerts
  • Log in
  • My Cart

Search

  • Advanced search
Anticancer Research
  • Other Publications
    • Anticancer Research
    • In Vivo
    • Cancer Genomics & Proteomics
  • Register
  • Subscribe
  • My alerts
  • Log in
  • My Cart
Anticancer Research

Advanced Search

  • Home
  • Current Issue
  • Archive
  • Info for
    • Authors
    • Editorial Policies
    • Subscribers
    • Advertisers
    • Editorial Board
    • Special Issues
  • Journal Metrics
  • Other Publications
    • In Vivo
    • Cancer Genomics & Proteomics
    • Cancer Diagnosis & Prognosis
  • More
    • IIAR
    • Conferences
    • 2008 Nobel Laureates
  • About Us
    • General Policy
    • Contact
  • Visit us on Facebook
  • Follow us on Linkedin
Research ArticleClinical Studies

Prognostic Impact of Prior Androgen Receptor Axis-targeting Agents in Cabazitaxel Chemotherapy After Docetaxel

MASAKI SHIOTA, MOTONOBU NAKAMURA, AKIRA YOKOMIZO, TOSHIHISA TOMODA, NAOTAKA SAKAMOTO, NARIHITO SEKI, SHUJI HASEGAWA, TAKAKAZU YUNOKI, MASAHIKO HARANO, KENTARO KUROIWA and MASATOSHI ETO
Anticancer Research January 2020, 40 (1) 335-339; DOI: https://doi.org/10.21873/anticanres.13957
MASAKI SHIOTA
1Department of Urology, Graduate School of Medical Sciences, Kyushu University, Fukuoka, Japan
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • For correspondence: shiota{at}uro.med.kyushu-u.ac.jp
MOTONOBU NAKAMURA
2Department of Urology, National Hospital Organization Kyushu Cancer Center, Fukuoka, Japan
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
AKIRA YOKOMIZO
3Division of Urology, Harasanshin Hospital, Fukuoka, Japan
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
TOSHIHISA TOMODA
4Department of Urology, Oita Prefectural Hospital, Oita, Japan
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
NAOTAKA SAKAMOTO
5Department of Urology, National Hospital Organization Kyushu Medical Center, Fukuoka, Japan
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
NARIHITO SEKI
6Department of Urology, Kyushu Central Hospital, Fukuoka, Japan
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
SHUJI HASEGAWA
7Department of Urology, Kitakyushu Municipal Medical Center, Kitakyushu, Japan
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
TAKAKAZU YUNOKI
8Department of Urology, Japanese Red Cross Fukuoka Hospital, Fukuoka, Japan
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
MASAHIKO HARANO
9Department of Urology, JCHO Kyushu Hospital, Kitakyushu, Japan
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
KENTARO KUROIWA
10Department of Urology, Miyazaki Prefectural Miyazaki Hospital, Miyazaki, Japan
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
MASATOSHI ETO
1Department of Urology, Graduate School of Medical Sciences, Kyushu University, Fukuoka, Japan
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • Article
  • Figures & Data
  • Info & Metrics
  • PDF
Loading

Article Information

vol. 40 no. 1 335-339
DOI 
https://doi.org/10.21873/anticanres.13957
PMID 
31892584

Published By 
International Institute of Anticancer Research
Print ISSN 
0250-7005
Online ISSN 
1791-7530
History 
  • Received November 18, 2019
  • Revision received November 22, 2019
  • Accepted November 25, 2019
  • Published online December 31, 2019.

Copyright & Usage 
Copyright© 2020, International Institute of Anticancer Research (Dr. George J. Delinasios), All rights reserved

Author Information

  1. MASAKI SHIOTA1⇑,
  2. MOTONOBU NAKAMURA2,
  3. AKIRA YOKOMIZO3,
  4. TOSHIHISA TOMODA4,
  5. NAOTAKA SAKAMOTO5,
  6. NARIHITO SEKI6,
  7. SHUJI HASEGAWA7,
  8. TAKAKAZU YUNOKI8,
  9. MASAHIKO HARANO9,
  10. KENTARO KUROIWA10 and
  11. MASATOSHI ETO1
  1. 1Department of Urology, Graduate School of Medical Sciences, Kyushu University, Fukuoka, Japan
  2. 2Department of Urology, National Hospital Organization Kyushu Cancer Center, Fukuoka, Japan
  3. 3Division of Urology, Harasanshin Hospital, Fukuoka, Japan
  4. 4Department of Urology, Oita Prefectural Hospital, Oita, Japan
  5. 5Department of Urology, National Hospital Organization Kyushu Medical Center, Fukuoka, Japan
  6. 6Department of Urology, Kyushu Central Hospital, Fukuoka, Japan
  7. 7Department of Urology, Kitakyushu Municipal Medical Center, Kitakyushu, Japan
  8. 8Department of Urology, Japanese Red Cross Fukuoka Hospital, Fukuoka, Japan
  9. 9Department of Urology, JCHO Kyushu Hospital, Kitakyushu, Japan
  10. 10Department of Urology, Miyazaki Prefectural Miyazaki Hospital, Miyazaki, Japan
  1. Correspondence to: Masaki Shiota, MD, Ph.D., Department of Urology, Graduate School of Medical Sciences, Kyushu University, 3-1-1 Maidashi, Higashi-ku, Fukuoka 812-8582, Japan. Tel: +81 926425603, Fax: +81 926425618, e-mail: shiota{at}uro.med.kyushu-u.ac.jp
View Full Text

Statistics from Altmetric.com

Cited By...

  • 2 Citations
  • Citations
  • Google Scholar

This article has not yet been cited by articles in journals that are participating in Crossref Cited-by Linking.

PreviousNext
Back to top

In this issue

Anticancer Research
Vol. 40, Issue 1
January 2020
  • Table of Contents
  • Table of Contents (PDF)
  • Index by author
  • Back Matter (PDF)
  • Ed Board (PDF)
  • Front Matter (PDF)
Print
Download PDF
Article Alerts
Sign In to Email Alerts with your Email Address
Email Article

Thank you for your interest in spreading the word on Anticancer Research.

NOTE: We only request your email address so that the person you are recommending the page to knows that you wanted them to see it, and that it is not junk mail. We do not capture any email address.

Enter multiple addresses on separate lines or separate them with commas.
Prognostic Impact of Prior Androgen Receptor Axis-targeting Agents in Cabazitaxel Chemotherapy After Docetaxel
(Your Name) has sent you a message from Anticancer Research
(Your Name) thought you would like to see the Anticancer Research web site.
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
12 + 0 =
Solve this simple math problem and enter the result. E.g. for 1+3, enter 4.
Citation Tools
Prognostic Impact of Prior Androgen Receptor Axis-targeting Agents in Cabazitaxel Chemotherapy After Docetaxel
MASAKI SHIOTA, MOTONOBU NAKAMURA, AKIRA YOKOMIZO, TOSHIHISA TOMODA, NAOTAKA SAKAMOTO, NARIHITO SEKI, SHUJI HASEGAWA, TAKAKAZU YUNOKI, MASAHIKO HARANO, KENTARO KUROIWA, MASATOSHI ETO
Anticancer Research Jan 2020, 40 (1) 335-339; DOI: 10.21873/anticanres.13957

Citation Manager Formats

  • BibTeX
  • Bookends
  • EasyBib
  • EndNote (tagged)
  • EndNote 8 (xml)
  • Medlars
  • Mendeley
  • Papers
  • RefWorks Tagged
  • Ref Manager
  • RIS
  • Zotero
Reprints and Permissions
Share
Prognostic Impact of Prior Androgen Receptor Axis-targeting Agents in Cabazitaxel Chemotherapy After Docetaxel
MASAKI SHIOTA, MOTONOBU NAKAMURA, AKIRA YOKOMIZO, TOSHIHISA TOMODA, NAOTAKA SAKAMOTO, NARIHITO SEKI, SHUJI HASEGAWA, TAKAKAZU YUNOKI, MASAHIKO HARANO, KENTARO KUROIWA, MASATOSHI ETO
Anticancer Research Jan 2020, 40 (1) 335-339; DOI: 10.21873/anticanres.13957
Twitter logo Facebook logo Mendeley logo
  • Tweet Widget
  • Facebook Like
  • Google Plus One

Jump to section

  • Article
    • Abstract
    • Patients and Methods
    • Results
    • Discussion
    • Conclusion
    • Acknowledgements
    • Footnotes
    • References
  • Figures & Data
  • Info & Metrics
  • PDF

Related Articles

Cited By...

  • No citing articles found.
  • Google Scholar

More in this TOC Section

  • Prognostic Impact of Lymph Node Ratio in Patients With Gastric Cancer Undergoing Curative Gastrectomy Post Neoadjuvant Chemotherapy
  • Postoperative Bleeding After Gastrectomy for Gastric Cancer in Patients Receiving Antiplatelet and/or Anticoagulation Treatment
  • Real-world Comparative Study of Androgen Receptor Signaling Inhibitors in Japanese Patients With Non-metastatic Castration-resistant Prostate Cancer
Show more Clinical Studies

Keywords

  • Abiraterone
  • androgen receptor
  • cabazitaxel
  • docetaxel
  • enzalutamide
  • Prostate cancer
Anticancer Research

© 2026 Anticancer Research

Powered by HighWire